Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd operates in the healthcare sector, providing medical services and solutions. The company generates revenue through its operations in this field.
Business. Concord Medical Services Holdings Ltd operates in the healthcare sector, providing medical services and solutions. The company generates revenue through its operations in this field.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Concord Medical Services Holdings Limited (CCM) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific events, numerical shifts, or strategic pivots can be identified from the available data to drive a narrative of change. The company’s current profile is characterized by minimal external engagement and visibility. Data indicates that CCM has only one listed officer, zero analyst coverage, and no membership in major indices. Furthermore, there are no identified top holders, suggesting a lack of significant institutional ownership or public tracking in the current dataset. Market sentiment and news activity have been entirely absent over the observed period. From June 27, 2026, through July 17, 2026, the daily dispatch count remained at zero, with no sentiment data recorded. This complete lack of news flow reinforces the status of the ticker as having no recent material developments or public discourse. Given the absence of material changes, watcher signals, or cross-source activity, the significance of CCM’s current state lies in its baseline status. Investors and analysts should note that the company lacks the typical markers of active market interest, such as analyst ratings or index inclusion, and has generated no recent news or sentiment signals. [doc:ccm-companyfacts]
Signals & dispatch
Composite-score breakdown
Synthesis
Concord Medical Services Holdings Ltd operates in the healthcare sector, providing medical services and solutions. The company generates revenue through its operations in this field.
Concord Medical Services Holdings Ltd's capital structure and liquidity position cannot be assessed due to the unavailability of financial snapshot data. The company's valuation snapshot indicates a market price of $3.95, but without additional financial metrics, a comprehensive analysis of its capital structure is not possible. The company's profitability and returns cannot be evaluated against industry_config preferred metrics or cohort medians, as no financial data is available for comparison. The segments and geographic exposure of the company are not disclosed, making it difficult to assess revenue concentration or geographic diversification. The growth trajectory of the company cannot be determined due to the lack of outlook numeric deltas and revenue history. Risk factors associated with the company are unknown, as the risk assessment indicates that no financial snapshot, source documents, or observations were available for this run. Recent events related to the company are limited to sparse public filing facts, with only text observations captured from recent filings.
Concord Medical Services Holdings Limited (CCM) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific events, numerical shifts, or strategic pivots can be identified from the available data to drive a narrative of change. The company’s current profile is characterized by minimal external engagement and visibility. Data indicates that CCM has only one listed officer, zero analyst coverage, and no membership in major indices. Furthermore, there are no identified top holders, suggesting a lack of significant institutional ownership or public tracking in the current dataset. Market sentiment and news activity have been entirely absent over the observed period. From June 27, 2026, through July 17, 2026, the daily dispatch count remained at zero, with no sentiment data recorded. This complete lack of news flow reinforces the status of the ticker as having no recent material developments or public discourse. Given the absence of material changes, watcher signals, or cross-source activity, the significance of CCM’s current state lies in its baseline status. Investors and analysts should note that the company lacks the typical markers of active market interest, such as analyst ratings or index inclusion, and has generated no recent news or sentiment signals. [doc:ccm-companyfacts]
- The company's financial and operational data is not available, limiting the ability to assess its performance.
- The classification of the company is uncertain, with low confidence in its industry and sector placement.
- The company's market price is known, but without additional financial metrics, a valuation analysis is not feasible.
- The risk profile of the company cannot be evaluated due to the lack of financial and risk assessment data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Concord Medical Services Holdings Ltd company facts · 2026-05-27
Ownership & reference
Leadership
- Jianyu YangChairman of the Board, Chief Executive Officer
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 68.8%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1.6%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 25.2%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 68.8%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 48.7%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 134.0%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -4.5%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 47.0%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 68.6%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -4.0%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 43.7%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -2.0%Derived (calculated)
- Net margin (FY 2025-12-31): -20.2%Derived (calculated)
- Gross margin (FY 2025-12-31): 5.6%Derived (calculated)
- Return on equity (FY 2025-12-31): 4.4%Derived (calculated)
- Return on assets (FY 2025-12-31): -1.4%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.48xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): -2.23xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -61.0%Derived (calculated)
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- Long-term debt (annual): USD 352.56MSEC XBRL filing
- Current assets (annual): USD 134.69MSEC XBRL filing
- Revenue (annual): USD 65.85MSEC XBRL filing